Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Endocrine 2CNS 1

Conditions

Neuroendocrine Tumors 7Neoplasms 6Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Carcinoid Tumor 5Stomach Neoplasms 4Esophageal Neoplasms 4Acromegaly 4Weight Loss 3Rectal Neoplasms 3Pancreatic Neoplasms 3Diarrhea 3Carcinoma 3Breast Neoplasms 3Vipoma 2Thymoma 2Somatostatinoma 2Pituitary Neoplasms 2Ovarian Neoplasms 2Neoplasm Metastasis 2Malnutrition 2Intestinal Obstruction 2Insulinoma 2Glucagonoma 2Colonic Neoplasms 2Carcinoma, Islet Cell 2Adenoma, Islet Cell 2Zollinger-Ellison Syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1

Interventions

pasireotide 5Octreotide 4pegvisomant 2Cabergoline 2lanreotide 1Surgical Procedures, Operative 1Dosage Forms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Acromegaly × Octreotide × Clear all
NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed
20 enrolled
CNSEndocrine

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

NCT00171886 2017-02-24

Octreotide Efficacy and Safety in First-line Acromegalic Patients

Novartis

Phase 4 Completed
20 enrolled

Acromegaly

NCT01029275 2014-07-31

SAPORO

University Hospital, Rouen

Phase NA Completed
89 enrolled
Endocrine

Acromegaly, Pituitary Neoplasms

NCT00616408 2008-02-15

Prediction of Tumor Shrinkage in Acromegaly

Federico II University

Completed
61 enrolled

Acromegaly

Data powered by HemOnc (CC BY 4.0) Colophon âš¡